IP Library › Assignment 047602/0480
Patent Assignment
Reel/Frame 047602/0480

Security Interest

Recorded: 2018-11-19 Pages: 6
Assignor
KALA PHARMACEUTICALS, INC.
Executed: 2018-10-01
Assignee
ATHYRIUM OPPORTUNITIES III ACQUISITION LP
530 FIFTH AVENUE, FLOOR 25, NEW YORK, NEW YORK, 10036
Covered Properties (2)
RET9 and VEGFR2 Inhibitors
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/184,760 →
Publication: US 2019/0077810
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 19, 2018
From: NOWAK, PAWEL WOJCIECH; ONG, WINSTON ZAPANTA
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 047237/0877 →
Assignment of Assignor's Interest Nov 8, 2018
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 047456/0976 →
Termination and Release of Security Interest in Patents at Reel and Frame: 047602 / 0480 & 047172 / 0481 May 5, 2021
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: KALA PHARMACEUTICALS, INC
Reel/Frame 056151/0092 →
Security Interest May 6, 2021
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 056168/0602 →
First Amendment to Ip Security Agreement Dec 22, 2022
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062205/0883 →
Change of Name Sep 21, 2023
From: KALA PHARMACEUTICALS, INC.
To: KALA BIO, INC.
Reel/Frame 065017/0488 →